Patent · US Active

Treatment of NAFLD and NASH

US10342770B2 · kind B2 · utility

3Cited by
20References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2018
Grant dateJul 9, 2019
Priority date—
Expiry dateDec 17, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P29/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.